Landscape

Auditory Neuropathy

Auditory Neuropathy has 16 tracked records across 15 named organizations, including 8 strong-evidence records and 6 active programs. Records with caveats and trial-derived candidates remain visible for deeper review.

All Programs Therapeutics Devices

Open filtered programs

Pipeline Records

strong evidence + caveats + candidates

Strong Evidence

8 checked records with caveats

Active Programs

currently active

Marketed / Approved

commercial or approved

Organizations

companies, sponsors, and institutions

Competitive Density

42/100

organization breadth + program volume

Pipeline Velocity

45/100

active and late-stage share

Evidence Coverage

50/100

share strong evidence

Completion Signal

100/100

late-stage, approved, or marketed

Attrition Rate

6/100

share discontinued

Concentration

13/100

top-organization share

Programs by Stage

Preclinical2 · 13%

Phase 1/23 · 19%

Phase 21 · 6%

Approved3 · 19%

Marketed7 · 44%

Trial / Program Status

Active6 · 38%

Marketed6 · 38%

Approved3 · 19%

Discontinued1 · 6%

Modality Breakdown

Diagnostic6 · 38%

BCI/Neurotech4 · 25%

Gene Therapy4 · 25%

Cell Therapy2 · 13%

Program Types

Diagnostic6 · 38%

Therapeutic6 · 38%

Device3 · 19%

Software/Neurotech1 · 6%

Top Organizations

Interacoustics2 · 13%

Cochlear1 · 6%

Eli Lilly and Company1 · 6%

Grason-Stadler1 · 6%

Institution-led study1 · 6%

Lineage Cell Therapeutics1 · 6%

MED-EL1 · 6%

Natus1 · 6%

Population Tags

adult12 · 75%

pediatric12 · 75%

congenital11 · 69%

profound6 · 38%

bilateral4 · 25%

genetic4 · 25%

otof-dfnb94 · 25%

auditory-brainstem-implant3 · 19%

implantable-neuroprosthesis3 · 19%

pre-lingual3 · 19%

Strong-Evidence Programs

8 records

Otarmeni by RegeneronStrong evidence

Company: Regeneron Pharmaceuticals · Approved · Approved

Gene TherapyApprovedApproved99% confidence

AK-OTOF by Eli Lilly and AkouosStrong evidence

Company: Eli Lilly and Company · Phase 2 · Active

Gene TherapyPhase 2Active95% confidence

SENS-501 by SensorionStrong evidence

Company: Sensorion · Phase 1/2 · Active

Gene TherapyPhase 1/2Active94% confidence

Rincell-1 by Rinri TherapeuticsStrong evidence

Company: Rinri Therapeutics · Phase 1/2 · Active

Cell TherapyPhase 1/2Active92% confidence

Cochlear Nucleus ABI541 Brainstem ImplantStrong evidence

Company: Cochlear · Approved · Approved

BCI/NeurotechApprovedApproved95% confidence

PATH MEDICAL SENTIERO ADVANCEDStrong evidence

Company: PATH MEDICAL · Marketed · Marketed

DiagnosticMarketedMarketed91% confidence

MED-EL SYNCHRONY ABI Auditory Brainstem ImplantStrong evidence

Company: MED-EL · Approved · Approved

BCI/NeurotechApprovedApproved89% confidence

ReSonance by Lineage Cell TherapeuticsStrong evidence

Company: Lineage Cell Therapeutics · Preclinical · Active

Cell TherapyPreclinicalActive87% confidence

Checked Records With Caveats

8 records

GSI Audera Pro

Company: Grason-Stadler · Marketed · Marketed

DiagnosticMarketedMarketed93% confidence

Bio-logic NavPRO ONE

Company: Natus · Marketed · Marketed

DiagnosticMarketedMarketed89% confidence

Otodynamics Otoport OAE+ABR

Company: Otodynamics · Marketed · Marketed

DiagnosticMarketedMarketed88% confidence

Interacoustics Eclipse

Company: Interacoustics · Marketed · Marketed

DiagnosticMarketedMarketed87% confidence

Interacoustics Titan

Company: Interacoustics · Marketed · Marketed

DiagnosticMarketedMarketed86% confidence

Oticon Medical Digisonic SP ABI Brainstem Implant

Company: Oticon Medical · Marketed · Discontinued

BCI/NeurotechMarketedDiscontinued86% confidence

Mass Eye and Ear / EPFL Soft Auditory Brainstem Implant

Sponsor / Institution: Institution-led study · Preclinical · Active

BCI/NeurotechPreclinicalActive84% confidence

EHT102 by EuHearingStatus caveat

Company: Shanghai EuHearing Therapeutics Co., Ltd · Phase 1/2 · Active

Gene TherapyPhase 1/2Active90% confidence